Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.67 |
| ▸ | LNPEP | Q9UIQ6 | 5/20 | 0.62 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | ERAP2 | Q6P179 | 4/20 | 0.53 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.53 |
| ▸ | TYMS | P04818 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.48 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.48 |
| ▸ | XDH | P47989 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10792638 | 0.85 | LCK (0.71) | LCKLNPEPRAB9AALDH1A1XDH | |
| SCHEMBL7712141 | 0.85 | CA2 (0.74) | LCKCA1CA2CA12CA9 | |
| SCHEMBL15976476 | 0.85 | LCK (0.71) | LCKLNPEPCA1CA2RAB9A | |
| SCHEMBL15976477 | 0.85 | LCK (0.71) | LCKLNPEPRAB9AALDH1A1XDH | |
| SCHEMBL10792628 | 0.85 | LCK (0.71) | LCKLNPEPRAB9AALDH1A1XDH | |
| SCHEMBL6267583 | 0.83 | LCK (0.70) | LCKLNPEPRAB9AALDH1A1XDH | |
| SCHEMBL11864242 | 0.82 | LCK (0.68) | LCKLNPEPCA1CA2ALDH1A1 | |
| SCHEMBL5310702 | 0.81 | LCK (0.67) | LCKLNPEPCA1CA2RAB9A | |
| SCHEMBL8008620 | 0.81 | LCK (0.67) | LCKLNPEPCA1CA2RAB9A | |
| SCHEMBL6139811 | 0.81 | LCK (0.67) | LCKGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005072723-A1 | PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYLPHENYL DERIVATIVES OF ROSMARINIC ACID FOR ANTICANCER | MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) | 2005-08-11 | — | — | WO | claimed |
| EP-1499585-A1 | DERIVATIVES OF HYDROXYPHENYL, A METHOD FOR PREPARING THEREOF AND THEIR PHARMACEUTICAL COMPOSITION | Mogam Biotechnology Research Institute (KR) | 2005-01-26 | — | — | EP | claimed |
| US-20040082664-A1 | Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition | MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) | 2004-04-29 | — | — | US | claimed |
| WO-2003089405-A1 | DERIVATIVES OF HYDROXYPHENYL, A METHOD FOR PREPARING THEREOF AND THEIR PHARMACEUTICAL COMPOSITION | MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) | 2003-10-30 | — | — | WO | claimed |
| WO-2005072723-A1 | PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYLPHENYL DERIVATIVES OF ROSMARINIC ACID FOR ANTICANCER | MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) | 2005-08-11 | — | — | WO | disclosed |
| EP-1499585-A1 | DERIVATIVES OF HYDROXYPHENYL, A METHOD FOR PREPARING THEREOF AND THEIR PHARMACEUTICAL COMPOSITION | Mogam Biotechnology Research Institute (KR) | 2005-01-26 | — | — | EP | disclosed |
| US-20040082664-A1 | Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition | MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) | 2004-04-29 | — | — | US | disclosed |
| WO-2003089405-A1 | DERIVATIVES OF HYDROXYPHENYL, A METHOD FOR PREPARING THEREOF AND THEIR PHARMACEUTICAL COMPOSITION | MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) | 2003-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082664-A1 | Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition | LCK, SRC, FYN | LCK 1/4885LNPEP 1345/4885CA1 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.